Do "minitransplantations" have "minitoxicity"?

被引：1

作者：

Abbott, BL ^{[1
]}

机构：

[1] Univ Missouri, Kansas City, MO 64110 USA

来源：

BLOOD | 2004年 / 104卷 / 05期

关键词：

D O I：

10.1182/blood-2004-06-2254

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Reduced intensity, or nonablative, conditioning regimens have made allogeneic hematopoietic transplantation available to patients ineligible for conventional ablative regimens.

引用

页码：1239 / 1240

页数：2

共 5 条

[1] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION [J].

CHARLSON, ME ;

POMPEI, P ;

ALES, KL ;

MACKENZIE, CR .

JOURNAL OF CHRONIC DISEASES, 1987, 40 (05) :373-383

[2] Acute and chronic Graft-versus-Host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation [J].

Couriel, DR ;

Saliba, RM ;

Giralt, S ;

Khouri, I ;

Andersson, B ;

de Lima, M ;

Hosing, C ;

Anderlini, P ;

Donato, M ;

Cleary, K ;

Gajewski, J ;

Neumann, J ;

Ippoliti, C ;

Rondon, G ;

Cohen, A ;

Champlin, R .

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (03) :178-185

[3] Transplant-lite:: Induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor cell transplantation as treatment for lymphoid malignancies [J].

Khouri, IF ;

Keating, M ;

Körbling, M ;

Przepiorka, D ;

Anderlini, P ;

O'Brien, S ;

Giralt, S ;

Ippoliti, C ;

von Wolff, B ;

Gajewski, J ;

Donato, M ;

Claxton, D ;

Ueno, N ;

Andersson, B ;

Gee, A ;

Champlin, R .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2817-2824

[4] Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects [J].

McSweeney, PA ;

Niederwieser, D ;

Shizuru, JA ;

Sandmaier, BM ;

Molina, AJ ;

Maloney, DG ;

Chauncey, TR ;

Gooley, TA ;

Hegenbart, U ;

Nash, RA ;

Radich, J ;

Wagner, JL ;

Minor, S ;

Appelbaum, FR ;

Bensinger, WI ;

Bryant, E ;

Flowers, MED ;

Georges, GE ;

Grumet, FC ;

Kiem, HP ;

Torok-Storb, B ;

Yu, G ;

Blume, KG ;

Storb, RF .

BLOOD, 2001, 97 (11) :3390-3400

[5] Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases [J].

Slavin, S ;

Nagler, A ;

Naparstek, E ;

Kapelushnik, Y ;

Aker, M ;

Cividalli, G ;

Varadi, G ;

Kirschbaum, M ;

Ackerstein, A ;

Samuel, S ;

Amar, A ;

Brautbar, C ;

Ben-Tal, O ;

Eldor, A ;

Or, R .

BLOOD, 1998, 91 (03) :756-763

← 1 →